| |
10th Annual LDI Scientific Retreat
Join us at this year’s conference as we celebrate the 10th edition of the LDI Scientific Retreat!Thursday, May 2 2019, 8:15 am - 5:30 pm Click here to register
[MORE...]
|
Study shows potential misuse of off-label prescription of gabapentinoid drugs
Epidemiologists at the Lady Davis Institute discover that a drug frequently used as an alternative to opioids in treating pain carries some similar potential risks for patients.
[MORE...]
|
A new “atlas” of genetic influences on osteoporosis will unlock better treatment options
Identifying more than 500 genetic determinants of bone mineral density, researchers expect to provide new opportunities for the development of novel drugs to prevent or treat osteoporosis.
[MORE...]
|
Common treatment for type 2 diabetes associated with rare, aggressive cance
Incretin-based drugs used to treat type 2 diabetes are associated with bile-duct cancer, a very rare but also extremely aggressive and deadly cancer, finds a study conducted at the Lady Davis Institute.
[MORE...]
|